Skip to content
OpenCapital
Get started

Maravai LifeSciences Holdings, Inc. MRVI Europe, the Middle East and Africa — Revenue

Other geography segments

North America
$35.69M+21.9%
Asia Pacific
$7.87M-25.4%
Latin and Central America
$329K+125%

Similar metrics at other companies

10x Genomics, Inc. logo
TXGEurope, Middle East and Africa — Revenue
$36.85M+15.5%
Sonos, Inc. logo
SONOEurope, Middle East and Africa ("EMEA") — Revenue
$83.16M+20.9%
Varonis Systems logo
VRNSEMEA — Revenue
$35.78M+26.0%
Itron logo
ITRIEurope, Middle East, and Africa — Revenue
$101.21M+5.1%
Freshworks, Inc. logo
FRSHEurope, Middle East and Africa — Revenue
$88.63M+16.9%
Kennametal logo
KMTEurope, the Middle East and Africa (EMEA) — Revenues, percent
30%-1.0pp

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$849.64M+186%
Enterprise value$954.59M+182%
P/S4.2×+2.9×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%—

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s europe, the middle east and africa — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s europe, the middle east and africa — revenue?
Maravai LifeSciences Holdings, Inc. (MRVI) reported europe, the middle east and africa — revenue of $21.95M in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s europe, the middle east and africa — revenue changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s europe, the middle east and africa — revenue increased by 219.1% year-over-year, from $6.88M to $21.95M.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s europe, the middle east and africa — revenue?
Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s europe, the middle east and africa — revenue has grown at a -47.2% compound annual growth rate (CAGR), from $397.67M to $30.92M.
What does europe, the middle east and africa — revenue mean?
This metric represents the total net sales generated from customers located within the Europe, Middle East, and Africa (EMEA) geographic region. It reflects the company's market penetration and demand for nucleic acid production and biologics safety testing products within these specific international markets. Monitoring this figure helps investors assess the company's global footprint and the performance of its regional sales and distribution strategies.